Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Seres Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 69 | 63 | −6 |
| Shares | 63.1M | 61.5M | −1.57M (−2.5%) |
| Value | $52.5M | $43.1M | −$9.41M (−17.9%) |
New holders (5)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 203,904 | $142.8K | 0.01% |
| Two Sigma Securities, LLC | 25,588 | $17.9K | 0.00% |
| Miller Financial Services LLC | 15,000 | $10.5K | 0.02% |
| Peapack Gladstone Financial Corp | 13,000 | $9.00K | 0.00% |
| Mission Wealth Management, LP | 11,495 | $8.05K | 0.00% |
Sold out (11)
Institutions that held Seres Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HighTower Advisors, LLC | 70,000 | $58.2K |
| Jane Street Group, LLC | 58,736 | $48.8K |
| HRT Financial LP | 26,868 | $22.0K |
| Catalyst Funds Management Pty Ltd | 24,900 | $20.7K |
| Simplex Trading, LLC | 24,756 | $20.0K |
| XTX Topco Ltd | 16,300 | $13.5K |
| Clear Creek Financial Management, LLC | 12,950 | $10.8K |
| Tower Research Capital LLC (TRC) | 9,325 | $7.75K |
| The PNC Financial Services Group, Inc. | 636 | $529 |
| Bell Investment Advisors, Inc | 611 | $508 |
| Larson Financial Group LLC | 235 | $195 |